Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

British Journal of Nutrition

Volumn 92, Issue 5, 2004, Pages 757-761

  Cani, Patrice D ^a   Montoya, Maite Lasa ^a   Neyrinck, Audrey M ^a   Delzenne, Nathalie M ^a   Lambert, Didier M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Appetite; Cannabinoids; Gastrointestinal peptides; Oleoylethanolamide; Rimonabant

Indexed keywords

ANOREXIGENIC AGENT; APPETITE STIMULANT; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; GHRELIN; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; N OLEOYLETHANOLAMINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CIRCULATION; CONTROLLED STUDY; DIET RESTRICTION; DRUG MECHANISM; FOOD DEPRIVATION; FOOD INTAKE; INJECTION; MALE; MODULATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STATISTICAL SIGNIFICANCE; UPPER GASTROINTESTINAL TRACT;

ANIMALS; APPETITE REGULATION; BLOOD GLUCOSE; BLOTTING, WESTERN; CANNABINOIDS; EATING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; MALE; OLEIC ACIDS; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PIPERIDINES; PROTEIN PRECURSORS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, DRUG;

ANIMALIA;

EID: 9444265979     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20041256     Document Type: Article

References (26)

1. 1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63, 908-914.
2. Black SC (2004) Cannabinoid receptor antagonists and obesity. Curr Opin Investig Drugs 5, 389-394.
3. 1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459, 97-105.
4. Chan JL, Bullen J, Lee JH, Yiannakouris N & Mantzoros CS (2004) Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 89, 335-343.
5. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R & Pagotto U (2003a) Endogenous cannabinoid system as a modulator of food intake. Int J Obesity 27, 289-301.
6. Cota D, Marsicano G, Tschop M, et al. (2003b) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 423-431.
7. Cowley MA, Smith RG, Diano S, et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661.
8. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE & Weigle DS (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719.
9. Di Marzo V, Goparaju SK, Wang L, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825.
10. Domonville de la Cour C, Bjorkqvist M, Sandvik AK, Bakke I, Zhao CM, Chen D & Hakanson R (2001) A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 99, 141-150.
11. Fu J, Gaetani S, Oveisi F, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90-93.
12. Gaetani S, Oveisi F & Piomelli D (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28, 1311-1316.
13. 1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22, 9612-9617.
14. Harrold JA & Williams G (2003) The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr 90, 729-734.
15. Hilairet S, Bouaboula M, Carriere D, Le Fur G & Casellas P (2003) Hypersensitization of the orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 278, 23731-23737.
16. Jonsson KO, Vandervoorde S, Lambert DM, Tiger G & Fowler CJ (2001) Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 133, 1263-1275.
17. Kirkham TC & Williams CM (2001) Endogenous cannabinoids and appetite. Nutr Res Rev 14, 65-86.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
19. Konturek SJ, Konturek JW, Pawlik T & Brzozowski T (2004) Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55, 137-154.
20. Lambert DM, DiPaolo FG, Sonveaux P, Kanyonoyo M, Govaerts SJ, Hermans E, Bueb J, Delzenne NM & Tschirhart EJ (1999) Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta 1440, 266-274.
21. Lambert DM, Vandevoorde S, Jonsson KO & Fowler CJ (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9, 663-674.
22. Meier JJ, Gallwitz B, Schmidt WE & Nauck MA (2002) Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440, 269-279.
23. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS & Koplan JP (2000) The continuing epidemic of obesity in the United States. JAMA 284, 1650-1651.
24. Rodriguez de Fonseca F, Navarro M, Gomez R, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414, 209-212.
25. Thorens B & Waeber G (1993) Glucagon-like peptide-1 and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42, 1219-1225.
26. Tschop M, Smiley DL & Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407, 908-913.